MetaCap

GoodRx Holdings Inc. Class A (GDRX)

NASDAQ: GDRXTechnologyEDP ServicesUSD

2.92-0.10 (-3.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GDRX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$996.14M
52-week range
1.77 – 3.89
Day range
2.91 – 3.09
Volume / Avg
2.01M / 1.09M
Beta
—
Next earnings
Nov 24, 2026

52-week range

$1.77$3.89

GDRX stock today

On Nov 20, GDRX ended the session at $2.92, shedding $0.10 (3.31%), versus the S&P 500's 3.70% decline. Shares are 24.9% below their 52-week high of $3.89, set on Aug 11, 2026 and 65.0% above the 52-week low of $1.77, in the middle of the past year's range. GDRX is up 7.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 7.7%.

At 58.4x trailing earnings, GoodRx trades above the peer-group median of 11.4x. Its forward P/E of 8.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Nov 24; analysts expect EPS of $0.04.

Summary generated from market data by MetaCap's automated system. Methodology

About GoodRx

Company profile

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.

Industry
EDP Services
CEO
Ms. Wendy Barnes
Headquarters
Santa Monica, CA
Employees
697
IPO year
2020
Website
goodrx.com

Financial highlights

Full financials

In fiscal 2025, GoodRx generated $796.9 million in revenue, up 0.6% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $30.4 million (+85.7% year over year), for a net margin of 3.8% versus a median of -3.4% in the prior 5 years. Gross margin was 92.8% (down from 93.9%) and operating margin 11.0%.

GoodRx annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$796.85M$792.32M$750.26M$766.55M$745.42M
Growth+0.57%+5.61%-2.12%+2.83%+35.36%
Net income$30.44M$16.39M$-8.87M$-32.83M$-25.25M
EPS (diluted)$0.09$0.04$-0.02$-0.08$-0.06

Analyst forecast

Forecast

Consensus (14 analysts)

hold

Avg. price target

$3.95+35.27%

  • Strong buy 1
  • Buy 3
  • Hold 8
  • Sell 0
  • Strong sell 2

Target range

Low $2.65High $5.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 24, 2026
EPS estimate
$0.04
Last reported (Sep/2026)
Nov 17, 2026
EPS actual vs est.
$0.04 vs $0.04

GDRX news

All GDRX news

GoodRx peers

Technology sector
GDRX peer companies
CompanyPrice% ChgMarket capCompare
WRDWeRide Inc. ADR2.99-8.58%$981.93Mvs GDRX
INODInnodata Inc.28.12-8.91%$966.84Mvs GDRX
UPWKUpwork Inc.8.55-2.40%$1.08Bvs GDRX
PLTKPlaytika Holding Corp.2.31-7.97%$883.98Mvs GDRX
OSPNOneSpan Inc.21.92-2.88%$808.73Mvs GDRX
TASKTaskUs Inc. Class A8.72+0.17%$799.90Mvs GDRX
DDIDoubleDown Interactive Co. Ltd. American Depository Shares15.31-0.26%$758.66Mvs GDRX
LZLegalZoom.com Inc.4.47-1.97%$738.26Mvs GDRX

Indexes, lists and sector

GoodRx stock FAQ

What is GoodRx's stock price today?

GDRX last traded at $2.92 as of Nov 20, 4:00 PM EST, down 3.31% on the day. Prices are delayed at least 15 minutes.

When is GoodRx's next earnings date?

GoodRx is expected to report earnings on Tuesday, November 24, 2026. Analysts expect EPS of $0.04.

What is GDRX's P/E ratio?

GDRX trades at a trailing P/E ratio of 58.40 and a forward P/E of 8.29, compared with a median of 11.4 for its closest peers.

Who is GoodRx's CEO?

Ms. Wendy Barnes is the chief executive officer of GoodRx Holdings Inc. Class A, which has about 697 employees.

What is the GDRX 52-week high?

The 52-week high for GDRX is $3.89 and the 52-week low is $1.77. The stock is currently 24.9% below its high.

Compare GDRX